Capital Fund Management (CFM)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Capital Fund Management (CFM)'s NVO Position: Q1 2026 in Review
Capital Fund Management (CFM) increased its Novo Nordisk (NVO) stake by 303% in Q1 2026, buying an estimated $19.6M and bringing the position to 549,373 shares worth $20.2M. The position accounts for 0.09% of the portfolio, ranked #307.
Capital Fund Management (CFM) first reported a position in NVO in Q2 2013 and has held it in 41 quarters since. The position peaked at $98.7M in Q1 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Capital Fund Management (CFM) held 549,373 shares of Novo Nordisk worth $20.2M as of Q1 2026.
- Capital Fund Management (CFM) bought 413,171 Novo Nordisk shares in Q1 2026, an estimated $19.6M.
- Novo Nordisk made up 0.09% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #307 holding.
- Capital Fund Management (CFM) first reported a position in Novo Nordisk in Q2 2013 and has held it in 41 quarters since.
- Capital Fund Management (CFM)'s Novo Nordisk position peaked at $98.7M in Q1 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.